Nihon Toseki Igakkai Zasshi
Online ISSN : 1883-082X
Print ISSN : 1340-3451
ISSN-L : 1340-3451
SARS-CoV-2 S1-RBD IgG titers before and after third heterologous booster vaccination with Moderna COVID-19 vaccine in hemodialysis patients
Kosuke OkudaAzusa TakahashiYoichi FurusawaHideaki Takahashi
Author information

2023 Volume 56 Issue 11 Pages 429-435


We measured Abbottʼs S1-RBD IgG antibody titers before and after the third dose of Modernaʼs COVID-19 vaccine in hemodialysis (HD) patients, and examined factors affecting antibody titers. We used Pfizerʼs BNT162b2 (Pfizer) until the second vaccination, and Modernaʼs mRNA-1273 (Moderna) for the third vaccination 6 months after the second vaccination. Antibody titers increased markedly from a median of 275 (149-571) AU/mL before vaccination to 29,737 (14,984-46,185) AU/mL (108.1-fold) one month after vaccination. Multiple regression analysis showed that post-immunization antibody titers were lower in steroid-naive patients, and were also lower in patients with a lower BMI with the exception of those with a BMI of 30 or higher. The results suggest that hemodialysis patients who show emaciation or take steroids need to take more care regarding infection protection after vaccination.

Content from these authors
© 2023 The Japanese Society for Dialysis Therapy
Previous article Next article